View More Recent Stories

Jun 17, 2024 06:23AM RBC Capital Reiterates Outperform Rating on Johnson & Johnson (JNJ)
Jun 14, 2024 08:02AM Johnson & Johnson (JNJ) reports TALVEY demonstrated highly durable, longer-term responses in patients with relapsed or refractory multiple myeloma
Jun 11, 2024 05:27AM BofA Securities Reiterates Neutral Rating on Johnson & Johnson (JNJ)
Jun 10, 2024 05:39AM RBC Capital Reiterates Outperform Rating on Johnson & Johnson (JNJ)
Apr 14, 2024 02:00PM Johnson & Johnson (JNJ) stock: 1Q24 earnings preview
View More Recent Stories